New medicine for rare bone disease

View source ↗

Summary

The EMA announces a new medicine for a rare bone disease, indicating regulatory approval or authorization for a previously untreated condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rare Bone Disease